SMTL ID : 7oao.1

Nanobody C5 bound to RBD

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

hetero-1-1-mer

Ligands

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain A: G.10, F.13, N.14, L.39 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:F.13, A:L.39 Hydrogen bonds: A:N.14

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 2 residues within 4Å: Chain A: F.135, R.137 3 PLIP interactions: 3 interactions with chain A Water bridges: A:R.26, A:R.137 Salt bridges: A:R.137

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Huo, J. et al., A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19. Nat Commun (2021)

Release Date

2021-08-11

Peptides

Spike protein S1: A
C5 nanobody: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
EEE

B
FFF

Spike protein S1

C5 nanobody

Related Entries With Identical Sequence